181 related articles for article (PubMed ID: 9828021)
1. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose.
Goodnough LT; Kuter D; McCullough J; Brecher ME
J Clin Apher; 1998; 13(3):114-9. PubMed ID: 9828021
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
[TBL] [Abstract][Full Text] [Related]
3. The use of PEG-rhuMGDF in platelet apheresis.
Kuter DJ
Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
[TBL] [Abstract][Full Text] [Related]
4. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].
Lozano ML; Rivera J; Vicente V
Med Clin (Barc); 2012 May; 138(12):528-33. PubMed ID: 21807386
[TBL] [Abstract][Full Text] [Related]
5. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
Xiao W; Tormey CA; Capetillo A; Maitta RW
Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
[TBL] [Abstract][Full Text] [Related]
7. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
Sloand EM; Yu M; Klein HG
Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
[TBL] [Abstract][Full Text] [Related]
8. Platelet Yield and Some Donor-Related Predictors in a Single Donor Apheresis: Report from a Nigerian Tertiary Hospital.
Ugwu GC; Okoye HC; Nnachi OC; Nwani E; Nnachi OA; Ezenwenyi IP; Ugwu NI; Okoye AE
West Afr J Med; 2022 Dec; 39(12):1280-1284. PubMed ID: 36583368
[TBL] [Abstract][Full Text] [Related]
9. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
Thiele T; Alt-Mayer T; Greinacher A; Bux J
Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
[TBL] [Abstract][Full Text] [Related]
10. Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective.
Sweeney JD; Petrucci J; Yankee R
Transfus Sci; 1997 Dec; 18(4):575-83. PubMed ID: 10178682
[TBL] [Abstract][Full Text] [Related]
11. Single donor platelets: can we afford to use them? Can we afford not to use them?
Zeger G; Williams CT; Shulman IA
Transfus Sci; 1997 Dec; 18(4):585-8. PubMed ID: 10178683
[TBL] [Abstract][Full Text] [Related]
12. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis.
Wollersheim J; Dautzenberg M; van de Griendt A; Sybesma B
Transfus Apher Sci; 2006 Apr; 34(2):179-86. PubMed ID: 16574489
[TBL] [Abstract][Full Text] [Related]
13. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
15. A clinical and laboratory study of platelet concentrates produced by pooled buffy coat and single donor apheresis technologies.
Bishop D; Tandy N; Anderson N; Bessos H; Seghatchian MJ
Transfus Sci; 1995 Jun; 16(2):187-8. PubMed ID: 10155738
[No Abstract] [Full Text] [Related]
16. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
17. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
18. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
Hirani R; Peberdy J; Mondy P
Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
[TBL] [Abstract][Full Text] [Related]
19. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
Riggert J; Humpe A; Simson G; Köhler M
Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
[TBL] [Abstract][Full Text] [Related]
20. Platelet concentrates, from whole blood or collected by apheresis?
van der Meer PF
Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
